New biodiesel assurance programme may not be enough
Companies worry new legislation may make biodiesel incompatible with refueling facilities

Biodiesel

New biodiesel assurance programme may not be enough

23 Apr, 2013

Published over 13 years ago. See the latest and most current information on Biodiesel.

The Environmental Protection Agency (EPA) has proposed a new biodiesel Quality Assurance Programme, but many are arguing that it may not be enough.

Both the American Fuel and Petrochemical Manufacturers (AFPM) and the American Petroleum Institute(API) have commented on the new proposal, raising their concerns over the new proposal.

Charles Drevna, President of AFPM, said: "EPA's proposal is a welcome attempt to address the significant fraud in the biofuel markets, but will not solve the systematic problems caused by the Renewable Fuel Standard (RFS) biofuel mandates. "These mandates will harm consumers as the EPA forces the consumption of increasing amounts of biofuels that are incompatible with today's cars and refuelling facilities."

The decision to provide a defence for refiners against fraud has been met with positivity from the industry, however many companies are questioning whether it is enough to address the problem. The proposal also covers wider issues than just biodiesel fraud, which companies within the industry believe should be the main focus in order to successfully deal with the issue.

The proposal has been described by Drevna as 'merely a band-aid on a gaping wound' and many companies are in full support of a more drastic solution.  

PIN 27.3 June/July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Microneedle patch enables real-time drug monitoring
Explore more Arrow
Envirotech Online
World Bank commits USD600m to clean air programmes in Uttar Pradesh and Haryana
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow